Article
Persistent high-risk human papillomavirus infections and other end-point markers of progressive cervical disease among women prospectively followed up in the New Independent States of the Former Soviet Union and the Latin American Screening study cohorts.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society - 1 Jul 2009
Syrjänen Kari, Shabalova Irena, Naud Paulo, Kozachenko Vladimir, Derchain Sophie, Zakharchenko Sergej, Roteli-Martins Cecilia, Nerovjna Raisa, Longatto-Filho Adhemar, Kljukina Ludmila, Tatti Silvio, Branovskaja Marina, Hammes Luciano Serpa, Branca Margherita, Grunjberga Valerija, Erzen Mojca, Sarian Luis Otavio, Juschenko Anna, Costa Silvano, Podistov Jurij, Syrjänen Stina
Abstract excerpt
BACKGROUND: New end points are needed in future human papillomavirus (HPV) vaccine efficacy studies that accurately predict disease progression. OBJECTIVES: Potential intermediate end points were analyzed in the combined New Independent States of the Former Soviet Union (NIS) and the Latin American Screening (LAMS) study cohorts. STUDY DESIGN AND METHODS: Data files of 2 international screening trials, the NIS (n...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.